Humana ended Friday's trading session up 20%, making it TheStreet's Move of the Day.
A sad day for American Express (AXP) as President Ed Gilligan passed away after 35 years at the company.
Shares of Humana (HUM) ended Friday's trading session up 20 percent, making it TheStreet's Move of the Day.
The class of cancer immunotherapy drugs which target the protein PD-1 is proving to be effective against advanced liver, head and neck, lung and colon cancers.
Lilly 'never stops innovating,' Jim Cramer said of the plan to test a new cancer drug combination.
U.S. stock futures are tipping into negative territory as investors think over GDP numbers that show a shrinking U.S. economy.
Puma Bio, embroiled in controversy over its breast cancer drug neratinib, is turning away some people from a company event during the American Society of Clinical Oncology (ASCO) annual meeting.
U.S. stock futures are sinking slightly as investors ready for unemployment numbers and pending home sales data. Chipmaker Avago Technologies is buying Broadcom for $37 billion.
Johnson & Johnson shares should move higher eventually, and here's how to use options to make money from such a move.
June has historically been one of the weakest months for equities, which means stock selection -- both buying and selling -- will be critical over the short term.
U.S. stock futures are tentatively rising as investors digest a big cable-TV deal and debate when the Federal Reserve will raise interest rates.
Buying stocks whose share prices are in the hundreds or thousands of dollars can be tough for retail investors without big bankrolls. But several ETFs exist that solve that problem.
Jim Cramer likes the 10 early-stage drugs J&J has in its pipeline, among other reasons.
These under-$10 biotech stocks are within range of triggering breakout trades.
With the first-quarter earnings season behind us, data from Thomson Reuters shows earnings grew at an anemic 2.3%, the lowest level in the last four quarters.
Select the service that is right for you!COMPARE ALL SERVICES
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV